The modulatory effect of gender and cytomegalovirus-seropositivity on circulating inflammatory factors and cognitive performance in elderly individuals

International Journal of Molecular Sciences

Volumn 20, Issue 4, 2019, Pages

  Di Benedetto, Svetlana ^a,b   Gaetjen, Marcel ^c   Müller, Ludmila ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Becton Dickinson GmbH Germany   (Germany)

Author keywords

Aging; Anti inflammatory cytokines; Cognition; Cytomegalovirus; Gender; Immunosenescence; Inflammaging; Pro inflammatory cytokines

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; CYTOKINE;

ADULT; AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COGNITION; CONFIRMATORY FACTOR ANALYSIS; CYTOMEGALOVIRUS; EPISODIC MEMORY; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; IMMUNOSENESCENCE; INFLAMMATION; LEARNING; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MODULATION; MONOCYTE; NEUTROPHIL; SEX DIFFERENCE; TRAINING; WORKING MEMORY; AGED; BLOOD; COGNITIVE AGING; CYTOMEGALOVIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; NORMAL HUMAN; SEX FACTOR; VIROLOGY;

AGED; AGING; BIOMARKERS; COGNITIVE AGING; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SEX FACTORS;

EID: 85065532362     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms20040990     Document Type: Article

References (101)

1. Franceschi, C.; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2014, 69(Suppl. 1), S4-S9.
2. Holmes, C.; Cunningham, C.; Zotova, E.;Woolford, J.; Dean, C.; Kerr, S.; Culliford, D.; Perry, V.H. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009, 73, 768-774.
3. King, E.; O’Brien, J.T.; Donaghy, P.; Morris, C.; Barnett, N.; Olsen, K.; Martin-Ruiz, C.; Taylor, J.P.; Thomas, A.J. Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias. J. Neurol. Neurosurg. Psychiatry 2018, 89, 339-345.
4. Franceschi, C.; Garagnani, P.; Vitale, G.; Capri, M.; Salvioli, S. Inflammaging and ‘Garb-aging’. Trends Endocrinol. Metab. 2017, 28, 199-212.
5. Di Benedetto, S.; Müller, L.; Wenger, E.; Duzel, S.; Pawelec, G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci. Biobehav. Rev. 2017, 75, 114-128.
6. Castro, A.M.; Macedo-de la Concha, L.E.; Pantoja-Meléndez, C.A. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Revista édica del Hospital General de México 2017, 80, 101-105.
7. Chupel, M.U.; Direito, F.; Furtado, G.E.; Minuzzi, L.G.; Pedrosa, F.M.; Colado, J.C.; Ferreira, J.P.; Filaire, E.; Teixeira, A.M. Strength Training Decreases Inflammation and Increases Cognition and Physical Fitness in Older Women with Cognitive Impairment. Front. Physiol. 2017, 8, 377.
8. Fülop, T.; Larbi, A.; Dupuis, G.; Le Page, A.; Frost, E.H.; Cohen, A.A.; Witkowski, J.M.; Franceschi, C. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front. Immunol.2017, 8, 1960.
9. Sawada, M.; Suzumura, A.; Marunouchi, T. TNF alpha induces IL-6 production by astrocytes but not by microglia. Brain Res. 1992, 583, 296-299.
10. Singh, T.; Newman, A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10, 319-329.
11. Steensberg, A.; Fischer, C.P.; Keller, C.; Moller, K.; Pedersen, B.K. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E433-E437.
12. Alvarez-Rodriguez, L.; Lopez-Hoyos, M.; Munoz-Cacho, P.; Martinez-Taboada, V.M. Aging is associated with circulating cytokine dysregulation. Cell. Immunol. 2012, 273, 124-132.
13. Dinarello, C.A. Interleukin-1 and interleukin-1 receptor antagonist. Nutrition 1995, 11, 492-494.
14. Audet, M.C.; Anisman, H. Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front. Cell. Neurosci. 2013, 7, 68.
15. Calabrese, F.; Rossetti, A.C.; Racagni, G.; Gass, P.; Riva, M.A.; Molteni, R. Brain-derived neurotrophic factor:A bridge between inflammation and neuroplasticity. Front. Cell. Neurosci. 2014, 8, 430.
16. Lutz, C.T.; Quinn, L.S. Sarcopenia, obesity, and natural killer cell immune senescence in aging: Altered cytokine levels as a common mechanism. Aging 2012, 4, 535-546.
17. O’Connor, J.C.; McCusker, R.H.; Strle, K.; Johnson, R.W.; Dantzer, R.; Kelley, K.W. Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology. Cell. Immunol.2008, 252, 91-110.
18. Biet, F.; Locht, C.; Kremer, L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med. 2002, 80, 147-162.
19. Shaw, A.C.; Joshi, S.; Greenwood, H.; Panda, A.; Lord, J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010, 22, 507-513.
20. Shaw, D.M.; Merien, F.; Braakhuis, A.; Dulson, D. T-cells and their cytokine production:The anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine 2017, 104, 136-142.
21. Arend, W.P.; Malyak, M.; Guthridge, C.J.; Gabay, C. Interleukin-1 receptor antagonist: Role in biology. Annu. Rev. Immunol. 1998, 16, 27-55.
22. La Rosa, C.; Diamond, D.J. The immune response to human CMV. Future Virol. 2012, 7, 279-293.
23. Müller, L.; Hamprecht, K.; Pawelec, G. The role of CMV in “immunosenescence”. In The Ageing Immune System and Health; Bueno, V., Lord, J.M., Jackson, T.A., Eds.; Springer: Cham, Switzerland, 2017; pp. 53-68.
24. Pawelec, G. Immunosenenescence: Role of cytomegalovirus. Exp. Gerontol. 2014, 54, 1-5.
25. Weltevrede, M.; Eilers, R.; de Melker, H.E.; van Baarle, D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review. Exp. Gerontol. 2016, 77, 87-95.
26. Nikolich-Zugich, J.; Goodrum, F.; Knox, K.; Smithey, M.J. Known unknowns: How might the persistent herpesvirome shape immunity and aging? Curr. Opin. Immunol. 2017, 48, 23-30.
27. Jackson, S.E.; Redeker, A.; Arens, R.; van Baarle, D.; van den Berg, S.P.H.; Benedict, C.A.; Cicin-Sain, L.; Hill, A.B.;Wills, M.R. CMV immune evasion and manipulation of the immune system with aging. Geroscience 2017, 39, 273-291.
28. Al-Attar, A.; Presnell, S.R.; Peterson, C.A.; Thomas, D.T.; Lutz, C.T. Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans. Data Brief 2016, 8, 536-544.
29. Bennett, J.M.; Glaser, R.; Malarkey,W.B.; Beversdorf, D.Q.; Peng, J.; Kiecolt-Glaser, J.K. Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav. Immun. 2012, 26, 739-746.
30. Simanek, A.M.; Cheng, C.; Yolken, R.; Uddin, M.; Galea, S.; Aiello, A.E. Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology 2014, 50, 139-148.
31. Wang, G.C.; Kao, W.H.; Murakami, P.; Xue, Q.L.; Chiou, R.B.; Detrick, B.; McDyer, J.F.; Semba, R.D.; Casolaro, V.; Walston, J.D.; et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am. J. Epidemiol. 2010, 171, 1144-1152.
32. Kilgour, A.H.; Firth, C.; Harrison, R.; Moss, P.; Bastin, M.E.;Wardlaw, J.M.; Deary, I.J.; Starr, J.M. Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly. Immun. Ageing 2013, 10, 33.
33. Barnes, L.L.; Capuano, A.W.; Aiello, A.E.; Turner, A.D.; Yolken, R.H.; Torrey, E.F.; Bennett, D.A. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J. Infect. Dis.2015, 211, 230-237.
34. Mathei, C.; Vaes, B.; Wallemacq, P.; Degryse, J. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J. Am. Geriatr. Soc. 2011, 59, 2201-2208.
35. Aiello, A.E.; Haan, M.; Blythe, L.; Moore, K.; Gonzalez, J.M.; Jagust, W. The influence of latent viral infection on rate of cognitive decline over 4 years. J. Am. Geriatr. Soc. 2006, 54, 1046-1054.
36. Gow, A.J.; Firth, C.M.; Harrison, R.; Starr, J.M.; Moss, P.; Deary, I.J. Cytomegalovirus infection and cognitive abilities in old age. Neurobiol. Aging 2013, 34, 1846-1852.
37. Ricci, G.; Pirillo, I.; Tomassoni, D.; Sirignano, A.; Grappasonni, I. Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates. Clin. Exp. Hypertens 2017, 39, 8-16.
38. Raz, N.; Yang, Y.; Dahle, C.L.; Land, S. Volume of white matter hyperintensities in healthy adults:Contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim. Biophys. Acta 2012, 1822, 361-369.
39. Solfrizzi, V.; Scafato, E.; Capurso, C.; D’Introno, A.; Colacicco, A.M.; Frisardi, V.; Vendemiale, G.; Baldereschi,M.; Crepaldi, G.; Di Carlo, A.; et al. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol. Aging 2011, 32, 1932-1941.
40. Ng, T.P.; Feng, L.; Nyunt, M.S.; Feng, L.; Gao, Q.; Lim, M.L.; Collinson, S.L.; Chong, M.S.; Lim, W.S.; Lee, T.S.; et al. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia:Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol. 2016, 73, 456-463.
41. Freeman, R.B., Jr. The ‘indirect’ effects of cytomegalovirus infection. Am. J. Transplant. 2009, 9, 2453-2458.
42. Wang, H.; Peng, G.; Bai, J.; He, B.; Huang, K.; Hu, X.; Liu, D. Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta-Analysis of Prospective Studies Up to 2016. J. Am. Heart Assoc. 2017, 6.
43. Caruso, C.; Accardi, G.; Virruso, C.; Candore, G. Sex, gender and immunosenescence: A key to understand the different lifespan between men and women? Immun. Ageing 2013, 10, 20.
44. Ghosh, S.; Klein, R.S. Sex Drives Dimorphic Immune Responses to Viral Infections. J. Immunol. 2017, 198, 1782-1790.
45. Klein, S.L.; Flanagan, K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016, 16, 626-638.
46. Bouman, A.; Schipper, M.; Heineman, M.J.; Faas, M.M. Gender difference in the non-specific and specific immune response in humans. Am. J. Reprod. Immunol. 2004, 52, 19-26.
47. Garcia Verdecia, B.; Saavedra Hernandez, D.; Lorenzo-Luaces, P.; de Jesus Badia Alvarez, T.; Leonard Rupale, I.; Mazorra Herrera, Z.; Crombet Ramos, T.; Lage Davila, A. Immunosenescence and gender: A study in healthy Cubans. Immun. Ageing 2013, 10, 16.
48. Hirokawa, K.; Utsuyama, M.; Hayashi, Y.; Kitagawa, M.; Makinodan, T.; Fulop, T. Slower immune system aging in women versus men in the Japanese population. Immun. Ageing 2013, 10, 19.
49. Yan, J.; Greer, J.M.; Hull, R.; O’Sullivan, J.D.; Henderson, R.D.; Read, S.J.; McCombe, P.A. The effect of ageing on human lymphocyte subsets: Comparison of males and females. Immun. Ageing 2010, 7, 4.
50. Di Benedetto, S.; Derhovanessian, E.; Steinhagen-Thiessen, E.; Goldeck, D.; Muller, L.; Pawelec, G. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: Results from the Berlin BASE-II Study. Biogerontology 2015, 16, 631-643.
51. van der Heiden, M.; van Zelm, M.C.; Bartol, S.J.; de Rond, L.G.; Berbers, G.A.; Boots, A.M.; Buisman, A.M. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci. Rep. 2016, 6, 26892.
52. Althouse, A.D. Adjust for Multiple Comparisons? It’s Not That Simple. Ann. Thorac. Surg. 2016, 101, 1644-1645.
53. Goetzl, E.J.; Huang, M.C.; Kon, J.; Patel, K.; Schwartz, J.B.; Fast, K.; Ferrucci, L.; Madara, K.; Taub, D.D.; Longo, D.L. Gender specificity of altered human immune cytokine profiles in aging. FASEB J. 2010, 24, 3580-3589.
54. Corcoran, M.P.; Meydani, M.; Lichtenstein, A.H.; Schaefer, E.J.; Dillard, A.; Lamon-Fava, S. Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J. Endocrinol. 2010, 206, 217-224.
55. Malkin, C.J.; Pugh, P.J.; Jones, R.D.; Kapoor, D.; Channer, K.S.; Jones, T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 2004, 89, 3313-3318.
56. Accardi, G.; Caruso, C. Immune-inflammatory responses in the elderly: An update. Immun. Ageing 2018, 15, 11.
57. Al-Attar, A.; Presnell, S.R.; Peterson, C.A.; Thomas, D.T.; Lutz, C.T. The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men. Mech. Ageing Dev. 2016, 156, 25-33.
58. Gubbels Bupp, M.R. Sex, the aging immune system, and chronic disease. Cell. Immunol. 2015, 294, 102-110.
59. Gubbels Bupp, M.R.; Potluri, T.; Fink, A.L.; Klein, S.L. The Confluence of Sex Hormones and Aging on Immunity. Front. Immunol. 2018, 9, 1269.
60. Ostan, R.; Monti, D.; Gueresi, P.; Bussolotto, M.; Franceschi, C.; Baggio, G. Gender, aging and longevity in humans: An update of an intriguing/neglected scenario paving the way to a gender-specific medicine. Clin. Sci. 2016, 130, 1711-1725.
61. Villacres, M.C.; Longmate, J.; Auge, C.; Diamond, D.J. Predominant type 1 CMV-specific memory T-helper response in humans: Evidence for gender differences in cytokine secretion. Hum. Immunol. 2004, 65, 476-485.
62. Kovats, S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell. Immunol. 2015, 294, 63-69.
63. Nakagomi, A.; Seino, Y.; Noma, S.; Kohashi, K.; Kosugi, M.; Kato, K.; Kusama, Y.; Atarashi, H.; Shimizu,W. Relationships between the Serum Cholesterol Levels, Production of Monocyte Proinflammatory Cytokines and Long-term Prognosis in Patients with Chronic Heart Failure. Intern. Med. 2014, 53, 2415-2424.
64. Feingold, K.R.; Grunfeld, C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl. 2), 97-101.
65. Odegaard, J.I.; Chawla, A. Old HDL learns a new (anti-inflammatory) trick. Nat. Immunol. 2014, 15, 138-139.
66. Khovidhunkit,W.; Kim, M.S.; Memon, R.A.; Shigenaga, J.K.; Moser, A.H.; Feingold, K.R.; Grunfeld, C. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J. Lipid Res. 2004, 45, 1169-1196.
67. Catapano, A.L.; Pirillo, A.; Norata, G.D. Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials. Br. J. Pharmacol. 2017, 174, 3973-3985.
68. Orsini, A.; Chiacchio, L.; Cinque, M.; Cocchiaro, C.; Schiappa, O.; Grossi, D. Effects of age, education and sex on two tests of immediate memory: A study of normal subjects from 20 to 99 years of age. Percept. Mot. Skills 1986, 63, 727-732.
69. Zhang, J.; Zhou, W.; Wang, L.; Zhang, X. Harvard Aging Brain Study. Gender differences of neuropsychological profiles in cognitively normal older people without amyloid pathology. Compr. Psychiatry 2017, 75, 22-26.
70. Munro, C.A.;Winicki, J.M.; Schretlen, D.J.; Gower, E.W.; Turano, K.A.; Munoz, B.; Keay, L.; Bandeen-Roche, K.; West, S.K. Sex differences in cognition in healthy elderly individuals. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 2012, 19, 759-768.
71. Al-Delaimy, W.K.; von Muhlen, D.; Barrett-Connor, E. Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women. J. Am. Geriatr. Soc. 2009, 57, 1441-1446.
72. Perice, L.; Barzilai, N.; Verghese, J.;Weiss, E.F.; Holtzer, R.; Cohen, P.; Milman, S. Lower circulating insulin-like growth factor-I is associated with better cognition in females with exceptional longevity without compromise to muscle mass and function. Aging 2016, 8, 2414-2424.
73. Wilson, C.J.; Finch, C.E.; Cohen, H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50, 2041-2056.
74. Shields, G.S.; Moons, W.G.; Slavich, G.M. Inflammation, Self-Regulation, and Health: An Immunologic Model of Self-Regulatory Failure. Perspect. Psychol. Sci. 2017, 12, 588-612.
75. Perry, R.T.; Collins, J.S.; Wiener, H.; Acton, R.; Go, R.C. The role of TNF and its receptors in Alzheimer’s disease. Neurobiol. Aging 2001, 22, 873-883.
76. Fiore,M.; Angelucci, F.; Alleva, E.; Branchi, I.; Probert, L.; Aloe, L. Learning performances, brainNGF distribution and NPY levels in transgenic mice expressing TNF-alpha. Behav. Brain Res. 2000, 112, 165-175.
77. Rizzo, F.R.; Musella, A.; De Vito, F.; Fresegna, D.; Bullitta, S.; Vanni, V.; Guadalupi, L.; Stampanoni Bassi, M.; Buttari, F.; Mandolesi, G.; et al. Tumor Necrosis Factor and Interleukin-1beta Modulate Synaptic Plasticity during Neuroinflammation. Neural Plast. 2018, 2018, 8430123.
78. Yirmiya, R.; Goshen, I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25, 181-213.
79. Lobo-Silva, D.; Carriche, G.M.; Castro, A.G.; Roque, S.; Saraiva, M. Balancing the immune response in the brain: IL-10 and its regulation. J. Neuroinflamm. 2016, 13, 297.
80. Morrisette-Thomas, V.; Cohen, A.A.; Fulop, T.; Riesco, E.; Legault, V.; Li, Q.; Milot, E.; Dusseault-Belanger, F.; Ferrucci, L. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech. Ageing Dev.2014, 139, 49-57.
81. Tegeler, C.; O’Sullivan, J.L.; Bucholtz, N.; Goldeck, D.; Pawelec, G.; Steinhagen-Thiessen, E.; Demuth, I. The inflammatory markers CRP, IL-6, and IL-10 are associated with cognitive function-data from the Berlin Aging Study II. Neurobiol. Aging 2016, 38, 112-117.
82. Marsland, A.L.; Gianaros, P.J.; Abramowitch, S.M.; Manuck, S.B.; Hariri, A.R. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 2008, 64, 484-490.
83. Jefferson, A.L.; Massaro, J.M.; Beiser, A.S.; Seshadri, S.; Larson, M.G.; Wolf, P.A.; Au, R.; Benjamin, E.J. Inflammatory markers and neuropsychological functioning: The Framingham Heart Study. Neuroepidemiology 2011, 37, 21-30.
84. Simpson, E.E.; Hodkinson, C.F.; Maylor, E.A.; McCormack, J.M.; Rae, G.; Strain, S.; Alexander, H.D.; Wallace, J.M. Intracellular cytokine production and cognition in healthy older adults. Psychoneuroendocrinology 2013, 38, 2196-2208.
85. Trompet, S.; de Craen, A.J.; Slagboom, P.; Shepherd, J.; Blauw, G.J.; Murphy, M.B.; Bollen, E.L.; Buckley, B.M.; Ford, I.; Gaw, A.; et al. Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain 2008, 131, 1069-1077.
86. Whiting, C.C.; Siebert, J.; Newman, A.M.; Du, H.W.; Alizadeh, A.A.; Goronzy, J.; Weyand, C.M.; Krishnan, E.; Fathman, C.G.; Maecker, H.T. Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging. PLoS ONE 2015, 10, e0133627.
87. de Jager, W.; Bourcier, K.; Rijkers, G.T.; Prakken, B.J.; Seyfert-Margolis, V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009, 10, 52.
88. Goldeck, D.; Pawelec, G.; Norman, K.; Steinhagen-Thiessen, E.; Oettinger, L.; Haehnel, K.; Demuth, I. No strong correlations between serum cytokine levels, CMV serostatus and hand-grip strength in older subjects in the Berlin BASE-II cohort. Biogerontology 2016, 17, 189-198.
89. Kern, P.A.; Ranganathan, S.; Li, C.; Wood, L.; Ranganathan, G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280, E745-E751.
90. Tate, J.;Ward, G. Interferences in immunoassay. Clin. Biochem. Rev. 2004, 25, 105-120.
91. Rios-Lugo, M.J.; Martin, C.; Alarcon, J.A.; Esquifino, A.; Barbieri, G.; Solano, P.; Sanz, M. Optimization of buffer solutions to analyze inflammatory cytokines in gingival crevicular fluid by multiplex flow cytometry. Med. Oral. Patol. Oral Cir. Bucal 2015, 20, e13-e16.
92. Chavance, M.; Escolano, S.; Romon, M.; Basdevant, A.; de Lauzon-Guillain, B.; Charles, M.A. Latent variables and structural equation models for longitudinal relationships: An illustration in nutritional epidemiology. BMC Med. Res. Methodol. 2010, 10, 37.
93. Düzel, S.; Buchmann, N.; Drewelies, J.; Gerstorf, D.; Lindenberger, U.; Steinhagen-Thiessen, E.; Norman, K.; Demuth, I. Validation of a single factor representing the indicators of metabolic syndrome as a continuous measure of metabolic load and its association with health and cognitive function. PLoS ONE 2018, 13, e0208231.
94. Helmstaedter, C.; Durwen, H.F. The Verbal Learning and Retention Test. A useful and differentiated tool in evaluating verbal memory performance. Schweiz Arch. Neurol. Psychiatr. (1985) 1990, 141, 21-30.
95. Lindenberger, U.; Mayr, U.; Kliegl, R. Speed and intelligence in old age. Psychol. Aging 1993, 8, 207-220.
96. Schmiedek, F.; Lovden, M.; Lindenberger, U. Hundred Days of Cognitive Training Enhance Broad Cognitive Abilities in Adulthood: Findings from the COGITO Study. Front. Aging Neurosci. 2010, 2.
97. Finkelstein, M.M.; Verma, D.K. Exposure estimation in the presence of nondetectable values: Another look. AIHAJ 2001, 62, 195-198.
98. Hewett, P.; Ganser, G.H. A comparison of several methods for analyzing censored data. Ann. Occup. Hyg.2007, 51, 611-632.
99. Ogden, T.L. Handling results below the level of detection. Ann. Occup. Hyg. 2010, 54, 255-256.
100. Hesterberg, T.; Monaghan, S.; Moore, D.S.; Clipson, A.; Epstein, R. Bootstrap Methods and Permutation Tests; W.H. Freeman and Company: New York, NY, USA, 2003.
101. Steiger, J.H. Testing Pattern Hypotheses On Correlation Matrices: Alternative Statistics And Some Empirical Results. Multivar. Behav. Res. 1980, 15, 335-352.